Structure
Biotechnology & Healthcare
AIC sector
Biotechnology & Healthcare
Base currency
GBX
Snapshot date
2025-08-31
Structure
Biotechnology & Healthcare
AIC sector
Biotechnology & Healthcare
Base currency
GBX
Snapshot date
2025-08-31
Share price
1120.00p
NAV / share
1159.90p2026-09-10
Premium / discount
-3.44%
| USA | 73.5% | |
| Bermuda | 5.6% | |
| Netherlands | 5.2% | |
| UK | 4.7% | |
| Cash near Cash | 4.5% | |
| Denmark | 3.5% | |
| Cayman Islands | 3.2% | |
| Canada | 2.0% | |
| Ireland | 2.0% | |
| Israel | 1.4% |
| Portfolio yield | 0.00% |
| Unlisted holdings | 103.00% |
| Cash & equivalents | 4.48% |
| Total assets | £281.5m |
| Revenue reserves | £0 |
| Net gearing | 6.70% |
| Gross gearing | 11.80% |
| Net cash | £0 |
| Gearing range (from) | — |
| Gearing range (to) | — |
| Shares in issue | 33,727,491 |
| Shares issued | 0 |
| Shares purchased | 559,987 |
| Treasury shares | 7,656,326 |
Structure
Biotechnology & Healthcare
AIC sector
Biotechnology & Healthcare
Base currency
GBX
Snapshot date
2025-08-31
Share price
1120.00p
NAV / share
1159.90p2026-09-10
Premium / discount
-3.44%
| USA | 73.5% | |
| Bermuda | 5.6% | |
| Netherlands | 5.2% | |
| UK | 4.7% | |
| Cash near Cash | 4.5% | |
| Denmark | 3.5% | |
| Cayman Islands | 3.2% | |
| Canada | 2.0% | |
| Ireland | 2.0% | |
| Israel | 1.4% |
| Portfolio yield | 0.00% |
| Unlisted holdings | 103.00% |
| Cash & equivalents | 4.48% |
| Total assets | £281.5m |
| Revenue reserves | £0 |
| Net gearing | 6.70% |
| Gross gearing | 11.80% |
| Net cash | £0 |
| Gearing range (from) | — |
| Gearing range (to) | — |
| Shares in issue | 33,727,491 |
| Shares issued | 0 |
| Shares purchased | 559,987 |
| Treasury shares | 7,656,326 |